Rise Advisors’s Sight Sciences SGHT Stock Holding History

Rise Advisors’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-140	Closed	-$482	–	1196
2025 Q3	$482	Buy	+140	New	+$521	﹤0.01%	1425

Other funds holding SGHT

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Rise Advisors's SGHT Position: Q4 2025 in Review

Rise Advisors sold out of Sight Sciences (SGHT) in Q4 2025, closing a stake of 140 shares — an estimated $482 sold.

Rise Advisors first reported a position in SGHT in Q3 2025 and held it in 1 quarter. The position peaked at $482 in Q3 2025. 111 funds tracked by Wall St. Rank hold SGHT as of Q4 2025.

Rise Advisors reported no remaining Sight Sciences position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 140 Sight Sciences shares in Q4 2025, an estimated $482.
Rise Advisors first reported a position in Sight Sciences in Q3 2025 and held it in 1 quarter.
Rise Advisors's Sight Sciences position peaked at $482 in Q3 2025.
111 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.